InformationInformation Center

23 2018-05
Application of Quadrivalent Influenza Vaccine (QIV)

Application of Quadrivalent Influenza Vaccine (QIV)

The Quadrivalent Influenza Vaccine developed by the Hualan Bio this time contains the above two influenza A and two influenza B antigens, covering more influenza epidemic types, which will effectively prevent and control influenza epidemic.

03 2018-05
Introduction of Shengming Bio

Introduction of Shengming Bio

Shengming Bio is wholly owned subsidiary of Hualan Group and can provide CRO and CMO services related to monoclonal antibody drugs that fully meet the requirements of CFDA/FDA.